News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific
Arndt Vogel/X
Apr 25, 2025, 12:50

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical School, shared an article by Choong-kun Lee, et al. on X:

“RW Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific.

  • 1,141 pts, 55.1% 2nd line.
  • mPFS 2.9; mOS: 8 mo.
  • Lenva better compared to Sora, TKI plus ICI promising.
  • IMbrave 251 phase-3 awaited!

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.

Authors: Choong-kun Lee, et al.

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Arndt Vogel Asia Pacific atezolizumab Bevacizumab cancer Choong-kun Lee fight against cancer Global fight against cancer Hannover Medical School HCC liver cancer OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 17:45
Tracey O'Brien: Celebrating the Expert and Compassionate People This National Palliative Care Week
Blog
May 16, 2025, 17:45
Douglas Hanahan Receives Pezcoller Foundation–AACR International Award for Cancer Research Excellence
Insight
May 16, 2025, 17:35
Amol Akhade: A New Era for Advanced Anal Cancer Treatment
Blog
May 16, 2025, 17:22
APHINITY Trial Update Shows OS Benefit with Pertuzumab in HER2+ Breast Cancer - ESMO
Blog
May 16, 2025, 17:20
Two Studies Presented at ESMO Breast 25 Highlight the Potential Benefits of Tailoring Chemotherapy
Blog
May 16, 2025, 17:04
Elia Seguí: Happy to have presented today at ESMO Breast 2025 our work on TLS in breast cancer
Blog
May 16, 2025, 16:52
ECOG-ACRIN Cancer Research Group Announces Spring 2025 Edith Peterson Mitchell Health Equity Scholarship Recipients
Blog
May 16, 2025, 16:47
Erin Polak: Barriers to Early Cancer Detection at ACS CAN National Forum
Science
May 16, 2025, 16:46
David R. Liu: A Medical Milestone in Patient-Specific Gene Editing - From design to dosing in 7 months
Blog
May 16, 2025, 16:35
Roberto Sabatini and Young Researchers Honored with Meet-URO Awards 2025
Blog
May 16, 2025, 16:32
Saddened to Share the Passing of Associate Professor Josh McCarroll - Children's Cancer Institute
Insight
May 16, 2025, 16:21
Amar Kishan: Proud to Share Outcomes for phase II SCIMITAR Trial Published in JAMA Oncology